| Name |
methylthioadenosine phosphorylase |
cell division cycle 25A |
| Structure |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
None
|
| GWAS |
- Adverse response to drug ( 30420678
)
- Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism ( 32438682
)
- Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes ( 29221444
)
- Coronary heart disease ( 21606135
)
- Cutaneous malignant melanoma ( 32341527
)
- Cutaneous nevi ( 19578365
)
- Diastolic blood pressure ( 28135244
)
- Diastolic blood pressure response to hydrochlorothiazide in hypertension ( 27802415
)
- Glycated hemoglobin levels ( 28898252
)
- Lung adenocarcinoma ( 28604730
)
- Lung cancer ( 28604730
)
- Lung cancer in never smokers ( 28604730
)
- Lung function in heavy smokers (low FEV1 vs high FEV1) ( 26423011
)
- Macular thickness ( 30535121
)
- Mean spheric corpuscular volume ( 32888494
)
- Melanoma ( 28212542
21983787
)
- Nevus count ( 30429480
)
- Nevus count or cutaneous melanoma ( 30429480
32341527
)
- Pediatric bone mineral content (radius) ( 26041818
)
- Pulse pressure ( 28135244
)
|
- A body shape index ( 34021172
)
- Body size at age 10 ( 32376654
)
- Brain morphology (min-P) ( 32665545
)
- Brain morphology (MOSTest) ( 32665545
)
- Coronary artery disease ( 29212778
)
- Cortical surface area (MOSTest) ( 32665545
)
- Diastolic blood pressure ( 27841878
)
- HDL cholesterol levels ( 32203549
)
- Household income (MTAG) ( 31844048
)
- Loneliness (multivariate analysis) ( 27629369
)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401
)
- Medication use (beta blocking agents) ( 31015401
)
- Medication use (diuretics) ( 31015401
)
- Pulse pressure ( 27841878
)
- Subcortical volume (min-P) ( 32665545
)
- Subcortical volume (MOSTest) ( 32665545
)
- Systolic blood pressure ( 27841878
27618447
)
- Waist circumference adjusted for body mass index ( 34021172
)
|
| Novel Interactors |
2 novel interactors:
PKD2
PLCB2
|
2 novel interactors:
CCR1
CTNNB1
|
| Interacting Genes |
7 interacting genes:
CDC25A
CENPH
EMC3
FOLH1
LYRM1
MYLIP
RELB
|
57 interacting genes:
APP
AR
BTRC
CAMK1D
CCNA1
CCNB1
CCNE1
CCNI
CDK1
CDK2
CDK5
CDKN3
CHEK1
CHEK2
CSNK1A1
CUL3
CUX1
DMD
DUSP8
EEF1A1
EGFR
EP300
FAM193B
FBXW11
FGF21
FTH1
HDAC11
HLA-C
HRAS
IL3RA
LMO2
MAP3K5
MAPK14
MCM3AP
MTAP
NAA10
NAA11
NFKBIB
NFYA
PEX19
PIM1
PIN1
PKM
POLR1D
RAF1
ROCK1
SCYL1
SMAD3
SOX5
SRC
UBB
VAMP8
XPO1
YWHAB
YWHAE
YWHAQ
YWHAZ
|
| Entrez ID |
4507 |
993 |
| HPRD ID |
01134
|
00305
|
| Ensembl ID |
ENSG00000099810
|
ENSG00000164045
|
| Uniprot IDs |
A0A384ME80
B4DUC8
Q13126
|
D8KXX0
K7N7S0
P30304
|
| PDB IDs |
1CB0
1CG6
1K27
1SD1
1SD2
3LN5
3OZC
3OZD
3OZE
5EUB
5TC5
5TC6
5TC7
5TC8
6DYZ
6DZ0
6DZ2
6DZ3
|
1C25
8ROZ
|
| GO Terms Enriched among Interactors |
|
|